Dopamine effects on frontal cortical blood flow and motor inhibition in Parkinson's disease

Anxiety and Depression

Long-Term Effects of Safinamide on Mood Fluctuations in Parkinson's Disease

J Parkinsons Dis.

Cattaneo C, Müller T, Bonizzoni E, Lazzeri G, Kottakis I, Keywood C

doi: 10.3233/JPD-171143.

Further Publications Neurology

Effects of dopamine on reinforcement learning in Parkinson's disease depend on motor phenotype

Brain

van Nuland AJ, Helmich RC, Dirkx MF, Zach H, Toni I, Cools R, den Ouden HEM

doi: 10.1093/brain/awaa335

Aging and Cognitive FunctionsAnxiety and Depression

The impact of Tai Chi and Qigong mind-body exercises on motor and non-motor function and quality of life in Parkinson's disease: A systematic review and meta-analysis

Parkinsonism Relat Disord.

Song R, Grabowska W, Park M, Osypiuk K, Vergara-Diaz GP, Bonato P, Hausdorff JM, Fox M, Sudarsky LR, Macklin E, Wayne PM

doi: 10.1016/

Stroke

Effect of Standard vs Intensive Blood Pressure Control on Cerebral Blood Flow in Small Vessel Disease: The PRESERVE Randomized Clinical Trial

JAMA Neurol.

Croall ID, Tozer DJ, Moynihan B, Khan U, O'Brien JT, Morris RG, Cambridge VC, Barrick TR, Blamire AM, Ford GA, Markus HS

doi: 10.1001/jamaneurol.

Spatio-temporal dynamics of cortical drive to human subthalamic nucleus neurons in Parkinson's disease

Neurobiol Dis.

Sharott A, Gulberti A, Hamel W, Köppen JA, Münchau A, Buhmann C, Pötter-Nerger M, Westphal M, Gerloff C, Moll CKE, Engel AK

doi: 10.1016/j.nbd.2018.01.001.

Parkinson’s Disease

Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study

Lancet Neurol.

Wilson H, Dervenoulas G, Pagano G, Koros C, Yousaf T, Picillo M, Polychronis S, Simitsi A, Giordano B, Chappell Z, Corcoran B, Stamelou M, Gunn RN, Pellecchia MT, Rabiner EA, Barone P, Stefanis L, Politis M

doi: 10.1016/S1474-4422

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial

Lancet Neurol.

Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR, Henriksen T, van Laar T, Spivey K, Vel S, Staines H, Lees A

doi: 10.1016/S1474-

Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation

Lancet Neurol.

Latourelle JC, Beste MT, Hadzi TC, Miller RE, Oppenheim JN, Valko MP, Wuest DM, Church BW, Khalil IG, Hayete B, Venuto CS

doi: 10.1016/

RECOMMENDED

Parkinson’s Disease

CSF and blood biomarkers for Parkinson's disease

Lancet Neurol.

Parnetti L, Gaetani L, Eusebi P, Paciotti S, Hansson O, El-Agnaf O, Mollenhauer B, Blennow K, Calabresi P

doi: 10.1016/S1474-4422(19)30024-9.

Related content

Long-Term Effects of Safinamide on Mood Fluctuations in Parkinson's Disease

Effects of dopamine on reinforcement learning in Parkinson's disease depend on motor phenotype

The impact of Tai Chi and Qigong mind-body exercises on motor and non-motor function and quality of life in Parkinson's disease: A systematic review and meta-analysis

Effect of Standard vs Intensive Blood Pressure Control on Cerebral Blood Flow in Small Vessel Disease: The PRESERVE Randomized Clinical Trial

Spatio-temporal dynamics of cortical drive to human subthalamic nucleus neurons in Parkinson's disease

Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial

Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation

CSF and blood biomarkers for Parkinson's disease